Insider Trading & Ownership - HSU ERIC C

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for HSU ERIC C

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-04
Expired
2024-03-05
3:20 pm
2019-03-04
2024-03-04
InMed Pharmaceuticals Inc.INMHSU ERIC C
Sr. VP, Pre-Clinical Res/Dev
309$052,545
(Direct)
View
2023-12-23
Option Award
2023-12-26
1:07 pm
N/A
2028-12-22
InMed Pharmaceuticals Inc.INMHSU ERIC C
Sr. VP, Pre-Clinical Res/Dev
45,000$052,854
(Direct)
View
2023-08-31
Expired
2023-08-31
5:22 pm
2018-08-31
2023-08-31
InMed Pharmaceuticals Inc.INMHSU ERIC C
Sr. VP, Pre-Clinical Res/Dev
327$07,854
(Direct)
View
2023-05-16
Expired
2023-05-16
6:00 pm
2018-05-16
2023-05-16
InMed Pharmaceuticals Inc.INMHSU ERIC C
Sr. VP, Pre-Clinical Res/Dev
152$08,181
(Direct)
View
2023-03-08
Expired
2023-03-09
3:45 pm
2018-03-08
2023-03-08
InMed Pharmaceuticals Inc.INMHSU ERIC C
Sr. VP, Pre-Clinical Res/Dev
545$08,333
(Direct)
View
2022-12-16
Option Award
2022-12-19
4:49 pm
N/A
2027-12-15
InMed Pharmaceuticals Inc.INMHSU ERIC C
Sr. VP, Pre-Clinical Res/Dev
4,200$08,878
(Direct)
View
2022-11-14
Disposition(A)
2022-11-18
7:35 pm
N/A
2027-11-13
InMed Pharmaceuticals Inc.INMHSU ERIC C
Sr. VP, Pre-Clinical Res/Dev
4,200$04,678
(Direct)
View
2022-11-14
Option Award
2022-11-15
7:48 pm
N/A
2027-11-13
InMed Pharmaceuticals Inc.INMHSU ERIC C
Sr. VP, Pre-Clinical Res/Dev
4,200$08,878
(Direct)
View
2021-10-18
Option Award
2021-10-19
6:22 pm
N/A
2026-10-17
InMed Pharmaceuticals Inc.INMHSU ERIC C
Sr. VP, Pre-Clinical Res/Dev
35,000$0116,969
(Direct)
View
2020-12-16
Option Award
2020-12-18
06:18 am
N/A
2025-12-15
InMed Pharmaceuticals Inc.INMHSU ERIC C
Sr. VP, Pre-Clinical Res/Dev
35,000$035,000
(Direct)
View

Ownership
2020-11-12
2:06 pm
N/A
N/A
InMed Pharmaceuticals Inc.INMHSU ERIC C
Sr VP, Pre-Clinical Res/Dev
0$048,242
(Direct)
View
(A) Indicate amendment filing.